8-19955873-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong
The NM_000237.3(LPL):โc.808C>Tโ(p.Arg270Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000867 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (โ โ ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R270H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000237.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LPL | NM_000237.3 | c.808C>T | p.Arg270Cys | missense_variant | 6/10 | ENST00000650287.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LPL | ENST00000650287.1 | c.808C>T | p.Arg270Cys | missense_variant | 6/10 | NM_000237.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251278Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135800
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727244
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74328
ClinVar
Submissions by phenotype
Hyperlipoproteinemia, type I Pathogenic:4
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | DASA | Jan 05, 2022 | The c.808C>T;p.(Arg270Cys) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (Clinvar ID: 1548; PMID: 29153744; 29748148; 9279761; 7906986) - PS4.The variant is present at low allele frequencies population databases (rs118204077โ gnomAD 0.00006572%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Arg270Cys) was detected in trans with a pathogenic variant (PMID: 29153744; 29748148; 7906986) - PM3. Pathogenic missense variant in this residue have been reported (Clinvar ID: 1530; PMID: 29748148) - PM5. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1994 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The LPL c.808C>T (p.Arg270Cys) variant has been reported in individuals affected with lipoprotein lipase deficiency (Rabacchi et al). This variant disrupts the p.Arg270 amino acid residue in LPL. Other variant(s) that disrupt this residue have been observed in individuals with LPL-related conditions (Gotoda et al., 1991), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. This variant has been reported to the ClinVar database as Pathogenic. The p.Arg270Cys variant is novel (not in any individuals) in 1000 Genomes. The amino acid Arg at position 270 is changed to a Cys changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted to be damaging by both SIFT and PolyPhen2. The residue is conserved across species. The amino acid change p.Arg270Cys in LPL is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:4
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg270 amino acid residue in LPL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1752947, 7906986, 25966443). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LPL protein function. ClinVar contains an entry for this variant (Variation ID: 1548). This variant is also known as p.Arg243Cys. This missense change has been observed in individuals with clinical features of lipoprotein lipase deficiency (PMID: 7906986, 25966443, 29153744). This variant is present in population databases (rs118204077, gnomAD 0.006%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 270 of the LPL protein (p.Arg270Cys). - |
Pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 09, 2022 | - - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2021 | The p.R270C pathogenic mutation (also known as c.808C>T and p.R243C), located in coding exon 6 of the LPL gene, results from a C to T substitution at nucleotide position 808. The arginine at codon 270 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported in subjects with features of lipoprotein lipase deficiency (LPL) and has been shown to have an impact on protein function (Gotoda T et al. J Clin Invest, 1991 12;88:1856-64; Rodrigues R et al. J Clin Lipidol Dec;10:394-409; Vidanapathirana DM et al. Glob Pediatr Health, 2017 Jun;4:2333794X17715839; Teramoto R et al. Atherosclerosis, 2018 02;269:272-278; Tada H et al. Clin Chim Acta, 2019 Jan;488:31-39). Other alterations affecting the same amino acid, p.R270H and p.R270G, have also been reported in association with LPL deficiency (Gotoda T et al. J Clin Invest, 1991 12;88:1856-64; Khovidhunkit W et al. J Clin Lipidol Nov;10:505-511.e1). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
LPL-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 26, 2023 | The LPL c.808C>T variant is predicted to result in the amino acid substitution p.Arg270Cys. This variant (aka Arg243Cys) has been previously reported in the heterozygous state, along with second plausible causative variants in the same gene, in two individuals who presented with suspected familial chylomicronemia (Ma et al. 1994. PubMed ID: 7906986). In vitro function studies indicated that the p.Arg270Cys variant resulted in catalytically defective LPL (Ma et al. 1994. PubMed ID: 7906986). This variant was also described in the compound heterozygous or homozygous states state in individuals who presented with familial chylomicronemia (Benlian et al. 1996. PubMed ID: 8778602; Teramoto et al. 2018. PubMed ID: 29153744). Different amino acid changes at this position (p.Arg270Gly, p.Arg270His, and p.Arg270Leu) have also been reported in patients with disease (DโErasmo et al. 2019. PubMed ID: 31619059, supplementary table 1; Rodrigues et al. 2016. PubMed ID: 27055971). This variant is reported in 0.0065% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at